Citryll raised €85M in a Series B round in Dec 2024. The company is based in Oss, Netherlands. Investors in the round: BioGeneration Ventures, BOM, Citryll’s founders and 6 others. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €85M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.